ACTG Form 4 — CFO Buys 7,700 Shares at $3.2658 on 08/11/2025
Rhea-AI Filing Summary
Zambito Michael SIKORYAK, identified on the filing as the issuer's Chief Financial Officer, reported a purchase of 7,700 shares of Acacia Research Corporation (ACTG) on 08/11/2025. The transaction was coded P for a purchase and was executed at a weighted average price of $3.2658, with the filing noting component trades priced between $3.25 and $3.32. Following the transaction the reporting person beneficially owned 7,700 shares in a direct capacity.
The Form 4 was signed by an attorney-in-fact, Jennifer Graff, on 08/12/2025. No derivative transactions or other securities classes are reported on this filing, and no amendments or additional material items are included.
Positive
- Insider purchase disclosed: CFO acquired 7,700 ACTG shares, demonstrating direct purchase and alignment with the issuer
- Complete disclosure: Filing includes weighted average price $3.2658 and footnote explaining the trade price range $3.25–$3.32
Negative
- None.
Insights
TL;DR: CFO purchased 7,700 ACTG shares at a weighted average price of $3.2658; transaction is disclosed via Form 4.
The filing documents a straightforward Section 16 purchase by the reporting officer on 08/11/2025. The disclosed weighted average price and the footnoted execution range ($3.25–$3.32) indicate multiple trades aggregated on a single Form 4. The absolute value of the purchase (~$25k) is small relative to typical market-capitalization thresholds, so the transaction is unlikely to be material to Acacia Research's valuation by itself. The disclosure is timely and complete for the reported non-derivative security.
TL;DR: Insider purchase properly reported; signature by attorney-in-fact is included and no conflicts or derivative holdings are disclosed.
The Form 4 shows the officer's direct acquisition of common stock and includes the explanatory footnote about weighted average pricing, satisfying disclosure expectations. The filing is signed by an attorney-in-fact (Jennifer Graff) on 08/12/2025, which is permissible when properly authorized. There are no indirect holdings or plan-based transactions disclosed, and no indications of unusual reporting practices in the submitted content.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | ACTG Common Stock | 7,700 | $3.2658 | $25K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.32, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form.
AI-generated analysis. How Rhea-AI works. Not financial advice.
